Search Results - "ARMAĞAN, Berkan"

Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease‐Modifying Therapies by Armağan, Berkan, Robinson, Susan A., Bazoberry, Adriana, Perin, Jamie, Grader‐Beck, Thomas, Akpek, Esen K., Kim, Jean, Baer, Alan N.

“…Objective To assess anti‐Ro52 and anti‐Ro60 serologic profiles as markers of clinically relevant phenotypic subsets of patients with Sjögren's syndrome (SS)…”
Get full text

Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study by Bilgin, Emre, Hayran, Mutlu, Erden, Abdulsamet, Armağan, Berkan, Sarı, Alper, Kılıç, Levent, Akdoğan, Ali, Karadağ, Ömer, Bilgen, Şule Apraş, Kiraz, Sedat, Ertenli, İhsan, Kalyoncu, Umut

“…Objective To identify several clinical and/or laboratory parameters which can differentiate adult-onset Still’s disease (AOSD) from other causes of fever of…”
Get full text

COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study by Güven, Serdar Can, Erden, Abdulsamet, Karakaş, Özlem, Armağan, Berkan, Usul, Eren, Omma, Ahmet, Küçükşahin, Orhan

“…Aim of this study is to investigate the course of coronavirus disease 2019 (COVID-19), in our cohort of familial Mediterranean fever (FMF) patients in means of…”
Get full text

Effects of anti‐SARS‐CoV‐2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort by Apaydin, Hakan, Erden, Abdulsamet, Güven, Serdar Can, Armağan, Berkan, Konak, Hatice Ecem, Polat, Bünyamin, Afşin, Yağnur, Kaygisiz, Merve, Omma, Ahmet, Kucuksahin, Orhan

“…Aim Vaccination represents a cornerstone in mastering the coronavirus disease 2019 (COVID‐19) pandemic. There is a paucity of data regarding the safety of…”
Get full text

Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study by Karakaş, Özlem, Erden, Abdulsamet, Armağan, Berkan, Güven, Serdar Can, Atalar, Ebru, Polat, Bünyamin, Omma, Ahmet, Küçükşahin, Orhan

“…The aim of this study is to evaluate development of side effects, thrombotic or obstetric complications in our antiphospholipid syndrome (APS) patient group,…”
Get full text

Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients by Omma, Ahmet, Erden, Abdulsamet, Apaydin, Hakan, Aslan, Meryem, Çamlı, Hüseyin, Şahiner, Enes Seyda, Güven, Serdar Can, Armağan, Berkan, Karaahmetoğlu, Selma, Ates, Ihsan, Kucuksahin, Orhan

“…Effectiveness of hydroxychloroquine against SARS-CoV-2 has been highly controversial. In our research, we aimed to investigate the effects of…”
Get full text

Neurological involvement in patients with primary Sjögren's syndrome: A retrospective cross-sectional study by Konak, Hatice, Gök, Kevser, Armağan, Berkan, Güven, Serdar, Atalar, Ebru, Apaydın, Hakan, Maraş, Yüksel, Erten, Şükran

“…Background: To determine the rate and types of neurological involvement in patients with primary Sjögren's syndrome (pSS) and to evaluate predictive clinical…”
Get full text

Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis by Ekici, Remzi, Erden, Abdulsamet, Güven, Serdar Can, Armağan, Berkan, Özdemir, Bahar, Karakaş, Özlem, Gök, Kevser, Omma, Ahmet, Küçükşahin, Orhan, Erten, Şükran

“…•Although the rate of sarcopenia detected at the time of diagnosis was 31.5% in patients with rheumatoid arthritis, a significant decrease in the rate was…”
Get full text

Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective by Koçak Ulucaköy, Rezan, Babaoğlu, Hakan, Kayacan Erdoğan, Esra, Orhan, Kevser, Atalar, Ebru, Güven, Serdar Can, Konak, Hatice Ecem, Özdemir Ulusoy, Bahar, Akyüz Dağlı, Pınar, Karakaş, Özlem, Apaydın, Hakan, Eksin, Mehmet Akif, Polat, Bünyamin, Esmer, Serdar, Dogan, İsmail, Maraş, Yüksel, Omma, Ahmet, Küçükşahin, Orhan, Erten, Şükran, Armağan, Berkan

“…Background . Inflammatory rheumatic diseases (IRDs) are often associated with multiple comorbidities. Managing comorbidities now seen as important as…”
Get full text

Moderation analysis exploring associations between age and mucocutaneous activity in Behçet’s syndrome: A multicenter study from Turkey by Mumcu, Gonca, Yay, Meral, Karaçaylı, Ümit, Aksoy, Aysun, Taş, Mehmet Nedim, Armağan, Berkan, Sarı, Alper, Bozca, Burçin Cansu, Tekgöz, Emre, Temiz Karadağ, Duygu, Badak, Suade Özlem, Tecer, Duygu, Yıldırım, Alper, Bes, Cemal, Şahin, Ali, Erken, Eren, Cefle, Ayse, Çınar, Muhammet, Yılmaz, Sedat, Alpsoy, Erkan, Boyvat, Ayşe, Şenel, Soner, Bilge, Şule Yaşar, Kaşifoğlu, Timuçin, Karadağ, Ömer, Aksu, Kenan, Keser, Gökhan, Alibaz‐Öner, Fatma, İnanç, Nevsun, Ergun, Tülin, Direskeneli, Haner

“…The aim of the present study was to examine the effects of age on mucocutaneous activity by using moderation analysis in Behçet’s syndrome (BS). In this…”
Get full text

A single center experience of intravenous immunoglobulin treatment in Covid-19 by Omma, Ahmet, Erden, Abdulsamet, Armağan, Berkan, Güven, Serdar Can, Karakaş, Özlem, Şahiner, Enes Seyda, Erdem, Deniz, İzdeş, Seval, Ateş, İhsan, Küçükşahin, Orhan

“…•IVIg had been reported to be used in management of severe Covid-19.•In our population IVIg was used mostly in severe, refractory and complicated cases.•In…”
Get full text

Reducing length of hospital stay with colchicine by Karakaş, Özlem, Erden, Abdulsamet, Güven, Serdar Can, Armağan, Berkan, Sahiner, Enes Seyda, Kurtipek, Ali Can, Inan, Osman, Gemcioglu, Emin, Ateş, İhsan, Omma, Ahmet, Küçüksahin, Orhan

“…Colchicine is an ancient agent with well-known anti-inflammatory effects and commonly used in treatment of hyperinflammatory conditions. It has been argued…”
Get full text

COVID‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab by Armağan, Berkan, Konak, Hatice Ecem, Özdemir, Bahar, Apaydın, Hakan, Atalar, Ebru, Akyüz Dağlı, Pınar, Güven, Serdar Can, Erden, Abdulsamet, Küçükşahin, Orhan, Omma, Ahmet, Erten, Şükran

“…Introduction Rituximab, which is used in autoimmune rheumatic diseases (ARD), can cause both an increased risk of development of COVID‐19 disease and…”
Get full text

The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies by Uzun, Güllü Sandal, Gököz, Özay, Oğüt, Betül, Heper, Aylin, Güreşçi, Servet, Kardaş, Rıza Can, Öztürk, Mehmet Akif, Uslu, Emine, Ateş, Aşkın, Armağan, Berkan, Omma, Ahmet, Kılıc, Levent, Karadag, Omer

“…Histopathological findings associated with definite vasculitis in temporal artery biopsy (TAB) defined in 2022 ACR/EULAR classification criteria for Giant Cell…”
Get full text

Assessment of Left Ventricular Diastolic Functions in Patients with Behçet's Disease by Şener, Yusuf Ziya, Okşul, Metin, Armağan, Berkan, Sarı, Alper, Kaya, Ergün Barış, Akdoğan, Ali

“…Intestinal, neurological, vascular and cardiac involvement can be seen in BD. While the most common cardiac manifeastation is pericardial effusion;…”
Get full text

Real-life parameters in rheumatology by Armağan, Berkan, Kılıç, Levent, Önen, Fatoş, Kiraz, Sedat

“…Real-world data is derived from many sources associated with outcomes in a heterogeneous patient population in real-world settings, such as patient surveys,…”
Get full text

Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement by Kart Bayram, Gözde Sevgi, Erden, Abdulsamet, Bayram, Doğan, Özdemir, Bahar, Karakaş, Özlem, Apaydın, Hakan, Ateş, Ortaç, Güven, Serdar Can, Armağan, Berkan, Gök, Kevser, Maraş, Yüksel, Omma, Ahmet, Küçükşahin, Orhan, Topçuoğlu, Canan, Erten, Şükran

“…Abstract Objective The aim of this study is to evaluate semaphorin 3A levels in patients with systemic lupus erythematosus (SLE) with and without renal…”
Get full text

Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis by Armağan, Berkan, Kılıç, Levent, Farisoğulları, Bayram, Yardımcı, Gözde Kübra, Bilgin, Emre, Bölek, Ertuğrul Çağrı, Karadağ, Ömer, Bilgen, Şule Apraş, Kiraz, Sedat, Ertenli, İhsan, Kalyoncu, Umut

“…The drug retention rate has been an important indicator for evaluating the treatment tolerance. Unfortunately, our knowledge of the secukinumab retention rate…”
Get full text

Rheumatology experience with FDG PET / CT in inflammation of unknown origin: a single - centre report for determining factors associated with diagnostic precision by Akyüz Dağlı, Pınar, Güven, Serdar Can, Coşkun, Nazım, Karakaş, Özlem, Armağan, Berkan, Orhan, Kevser, Doğan, İsmail, Maraş, Yüksel, Türkölmez, Şeyda, Erten, Şükran

“…Background / aim The use of PET / CT is becoming more common in the elucidation of inflammatory processes in which the underlying cause cannot be determined by…”
Get full text

Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity by Akyüz Dağlı, Pınar, Erden, Abdulsamet, Babaoğlu, Hakan, Karakaş, Özlem, Özdemir Ulusoy, Bahar, Konak, Hatice Ecem, Armağan, Berkan, Erten, Şükran, Omma, Ahmet

“…Background Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by persistent antiphospholipid antibodies (aPLs) with arterial and…”
Get full text